| Application no. and date | 17196501.5 (espacenet) (Federated) (European Patent Register), 20041118 | | Patent/reg. no. and date | DK/EP 3300721, 20190306 | | Publication date | 20180404 | | Priority no. and date | DK 200301719, 20031120 | | EP pub. no. and date |
EP 3300721 20180404 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P68455DK01 | | Inventor | Pedersen, Tina Bjeldskov, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
Bonde, Claude, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
Engelund, Dorthe Kot, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 47/10 (2017.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) | | Title | PROPYLENGLYCOL-HOLDIGE PEPTIDFORMULERINGER HVILKE ER OPTIMALE TIL FREMSTILLING OG TIL ANVENDELSE I INJEKTIONSINDRETNINGER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
